Format

Send to

Choose Destination
Metabolism. 2015 Feb;64(2):274-82. doi: 10.1016/j.metabol.2014.10.005. Epub 2014 Oct 13.

The addition of medium-chain triglycerides to a purified fish oil-based diet alters inflammatory profiles in mice.

Author information

1
Boston Children's Hospital Department of Surgery and the Vascular Biology Program, Boston MA.
2
Boston Children's Hospital Clinical Research Center, Boston MA.
3
Boston Children's Hospital Department of Pharmacy, Boston MA.
4
Massachusetts General Hospital Department of Pathology, Boston MA.
5
Beth Israel Deaconess Medical Center Department of Medicine, Boston MA.
6
Boston Children's Hospital Department of Surgery and the Vascular Biology Program, Boston MA. Electronic address: mark.puder@childrens.harvard.edu.

Abstract

OBJECTIVE:

Parenteral nutrition associated liver disease (PNALD) is a deadly complication of long term parenteral nutrition (PN) use in infants. Fish oil-based lipid emulsion has been shown in recent years to effectively treat PNALD. Alternative fat sources free of essential fatty acids have recently been investigated for health benefits related to decreased inflammatory response. We hypothesized that the addition of medium-chain triglycerides (MCT) to a purified fish oil-based diet would decrease the response to inflammatory challenge in mice, while allowing for sufficient growth and development.

MATERIALS/METHODS:

Six groups of ten adult male C57/Bl6 mice were pair-fed different dietary treatments for a period of twelve weeks, varying only in fat source (percent calories by weight): 10.84% soybean oil (SOY), 10% coconut oil (HCO), 10% medium-chain triglycerides (MCT), 3% purified fish oil (PFO), 3% purified fish oil with 3% medium-chain triglycerides (50:50 MCT:PFO) and 3% purified fish oil with 7.59% medium-chain triglycerides (70:30 MCT:PFO). An endotoxin challenge was administered to half of the animals in each group at the completion of dietary treatment.

RESULTS:

All groups demonstrated normal growth throughout the study period. Groups fed MCT and HCO diets demonstrated biochemical essential fatty acid deficiency and decreased IL-6 and TNF-α response to endotoxin challenge. Groups containing PFO had increased inflammatory response to endotoxin challenge, and the addition of MCT to PFO mitigated this inflammatory response.

CONCLUSION:

These results suggest that the addition of MCT to PFO formulations may decrease the host response to inflammatory challenge, which may pose potential for optimized PN formulations. Inclusion of MCT in lipid emulsions given with PN formulations may be of use in therapeutic interventions for disease states resulting from chronic inflammation.

KEYWORDS:

Fish oil; Inflammation; Medium-chain triglycerides; Parenteral nutrition

PMID:
25458829
PMCID:
PMC4277814
DOI:
10.1016/j.metabol.2014.10.005
[Indexed for MEDLINE]
Free PMC Article

Publication types, MeSH terms, Substances, Grant support

Publication types

MeSH terms

Substances

Grant support

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center